Feedback (GB:FDBK) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Feedback PLC, a specialist in clinical infrastructure, reported a 15% increase in revenue to £1.18 million for the year ending May 2024, driven primarily by its Bleepa® platform. Despite a challenging domestic market, the company secured new contracts and renewals at higher prices with the NHS, while expanding into the UK private sector and India for tuberculosis screening. Feedback also aims to scale its digital solutions rapidly, supported by eligibility for Elective Recovery Fund funding and collaborations to enhance its product functionality.
For further insights into GB:FDBK stock, check out TipRanks’ Stock Analysis page.
